for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

4d Pharma PLC

DDDD.L

現在値

65.60GBp

変化

-4.40(-6.29%)

出来高

2,219,448

本日のレンジ

64.60

 - 

70.70

52週レンジ

64.60

 - 

183.00

∙ 約20分前の相場を表示しています。

価格

前日終値
70.00
始値
69.50
出来高
2,219,448
3か月平均出来高
26.94
高値
70.70
安値
64.60
52週高値
183.00
52週安値
64.60
発行済株式数
180.30
時価総額
126.21
予想PER
-5.15
配当利回り
--

次のエベント

Half Year 2021 4D Pharma PLC Earnings Release

適時開示

その他

4D Pharma PLC - Have Filed Registration Statement Of Which This Prospectus Forms Part With Respect To 22.4 Million Ordinary Shares Held By Shareholders

4D Pharma PLC says collaboration with Parkinson's UK

4D Pharma FY Diluted Loss/Share 22.8p

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

4d Pharma PLCとは

4D pharma plc (4D), formerly Schosween 18 Limited, is a United Kingdom-based pharmaceutical company focusing on developing various projects targeting new therapeutic areas. The principal activity of the Company is research and development of pharmaceutical products in new live biotherapeutic areas. The Company has developed its research to build MicroRx, which is a discovery methodology that is able to rationally select those bacteria that have a precise and evolved therapeutic effect. Its MicroRx methodology offers a pipeline of approximately 10 therapeutic programs covering autoimmune diseases, central nervous system (CNS) disorders and cancer. The Company uses MicroRx to develop its programs into the clinic and has approximately two programs in patient trials. The Company focuses on immune conditions, such as pediatric Crohn's, pediatric colitis and irritable bowel syndrome.

業種

Biotechnology & Drugs

連絡先

9 Bond Court

LS1 2JZ

United Kingdom

+44.113.8950130

https://www.4dpharmaplc.com/

エグゼクティブリーダーシップ

Axel Glasmacher

Non-Executive Independent Chairman of the Board

Duncan Joseph Peyton

Chief Executive Officer, Executive Director

Alexander James Stevenson

Chief Scientific Officer, Executive Director

Glenn Dourado

Chief Business Officer

Edgardo Baracchini

Non-Executive Independent Director

統計

2.00 mean rating - 1 analysts
Sell
Hold
Buy
Revenue (MM, GBP)

2018

0.0K

2020

0.0K

2021(E)

0.0K
EPS (GBp)

2018

-36.170

2019

-40.810

2020

-22.800

2021(E)

-13.600
株価売上高倍率(過去12カ月)
--
株価売上高倍率(過去12カ月)
236.35
株価純資産倍率(四半期)
3.29
株価キャッシュフロー倍率
--
総負債/総資本(四半期)
3.79
長期負債/資本(四半期)
3.53
投資利益率(過去12カ月)
-97.39
自己資本利益率(過去12カ月)
-78.64

最新ニュース

最新ニュース

金融情報はリフィニティブから。すべての情報は少なくとも20分遅れで表示されています。

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up